Pharmafile Logo
Pharmafocus logo
Advanced Search

medicinal cannabis

Showing 6 posts of 6 posts found.

_dsc6538

Medical cannabis: On to greener pastures?

October 14, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing medical cannabis, medicinal cannabis, pharma

In the first of three articles on the topic, Callum McGuinn, Associate and European Patent Attorney at Mewburn Ellis, explores …

Feature
pharmafocus_sept_2019_cover

Read the September edition of Pharmafocus online now!

September 12, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, brexit, lung cancer, medicinal cannabis, pharma

The latest monthly edition of Pharmafocus, the September issue, is available to read for free online now!With a new Prime …

News
cannabis-2152604_960_720

Hundreds of patients turn to private cannabis clinics in UK

August 16, 2019
Medical Communications Marijuana, NHS, UK, cannabis, medicinal cannabis, pharma

Hundreds of people have turned to private clinics, in an effort to gain access to medicinal cannabis in the UK, …

News
medicinal_cannabis_uk_review

UK Government call for more research into medicinal cannabis

July 4, 2019
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CBMP, Marijuana, UK, medicinal cannabis, pharma, politics

The British government has called for more research into cannabis-based medicinal products (CBMPs). In a paper published on 3 July, …

News

Fewer opioids prescribed in states with medical marijuana, research shows

June 12, 2019
Research and Development Marijuana, medicinal cannabis, opioids, pharma

Fewer opioids are prescribed in states with legal medical marijuana, according to research from University of Texas Medical Branch at …

News
cannabis-2152604_960_720

Synthetic, non-intoxicating CBD analogue treats seizures in rats

May 31, 2019
Medical Communications CBD, H2CBD, cannabidiol, medicinal cannabis, pharma

A synthetic, non-intoxicating cannabidiol (CBD)-analogue is effective at treating seizures in rats, according to researchers at the University of California, …

News

Latest content

Sanofi shares results from phase 2 trial for frexalimab in MS treatment

July 1, 2024

EMA accepts AstraZeneca’s regulatory submission for sipavibart for COVID-19 prevention

July 1, 2024

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024